We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
CONMED
CNMD
$1.48B
| $6.95M | 0.01% |
101,534
| – | – |
|
377
Quanex
NX
$967M
| $6.58M | 0.01% |
271,435
-94,082
| -26% | -$2.7M |
|
378
Delek US
DK
$3.72B
| $6.52M | 0.01% |
352,350
| – | – |
|
379
Vanguard Total Corporate Bond ETF
VTC
$1.71B
| $6.47M | 0.01% |
85,515
+5,645
| +7% | +$436K |
|
380
Coca-Cola
KO
$374B
| $6.29M | 0.01% |
101,078
-9,848
| -9% | -$643K |
|
381
iShares Russell 1000 Value ETF
IWD
$84.2B
| $6.17M | 0.01% |
33,306
| – | – |
|
382
Atkore
ATKR
$3.17B
| $6.11M | 0.01% |
73,187
-5,828
| -7% | -$514K |
|
383
Spectrum Brands
SPB
$2.02B
| $6.05M | 0.01% |
71,628
| – | – |
|
384
Pure Cycle
PCYO
$270M
| $5.96M | 0.01% |
470,090
-18,000
| -4% | -$220K |
|
385
Williams Companies
WMB
$87.9B
| $5.96M | 0.01% |
110,119
-27,508
| -20% | -$1.48M |
|
386
American Tower
AMT
$78.8B
| $5.82M | 0.01% |
31,700
-13,273
| -30% | -$2.75M |
|
387
Fastenal
FAST
$59.8B
| $5.67M | 0.01% |
157,574
-55,760
| -26% | -$2.18M |
|
388
Duke Energy
DUK
$94.5B
| $5.63M | 0.01% |
52,275
-11,679
| -18% | -$1.32M |
|
389
Microchip Technology
MCHP
$44.2B
| $5.53M | 0.01% |
96,405
+13,307
| +16% | +$915K |
|
390
Vishay Intertechnology
VSH
$5.08B
| $5.46M | 0.01% |
+322,055
| New | +$5.65M |
|
391
Fluor
FLR
$7.3B
| $5.23M | 0.01% |
+106,013
| New | +$5.59M |
|
392
Kimberly-Clark
KMB
$35.9B
| $5.02M | 0.01% |
38,313
+33,310
| +666% | +$4.54M |
|
393
Cable One
CABO
$203M
| $4.93M | 0.01% |
13,609
-673
| -5% | -$252K |
|
394
iShares Russell 2000 ETF
IWM
$81.5B
| $4.89M | 0.01% |
22,142
+917
| +4% | +$209K |
|
|
DESP
395
DELISTED
Despegar.com
DESP
| $4.44M | 0.01% |
230,687
-515,767
| -69% | -$8.12M |
|
396
Walmart Inc
WMT
$897B
| $4.42M | 0.01% |
48,982
-39,494
| -45% | -$3.43M |
|
|
APO.PRA
397
DELISTED
Apollo Global Management Series A
APO.PRA
| $4.36M | 0.01% |
26,383
-89,722
| -77% | -$7.53M |
|
398
Hanmi Financial
HAFC
$939M
| $4.26M | 0.01% |
+180,429
| New | +$4.23M |
|
|
SVCO
399
Silvaco Group
SVCO
$247M
| $4.26M | 0.01% |
527,500
| – | – |
|
400
InMode
INMD
$873M
| $4.25M | 0.01% |
254,420
-27,644
| -10% | -$490K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.